Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer

A. Cometta, S. Zinner, R. De Bock, T. Calandra, H. Gaya, J. Klastersky, J. Langenaeken, M. Paesmans, C. Viscoli, M. P. Glauser, B. Gibson, M. Sanz, I. M. Hann, F. Follath, R. Fatio, A. Cometta, A. Ferster, A. Van Hoof, H. Van Landuyt

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences